Tailoring hydrogen sulfide as therapeutic target in multiple sclerosis? Upregulation of tolerogenic pathways in dendritic cell and T cells from mice with EAE by the hydrogen sulfide donor GYY4137 and potentially impaired production of endogenous H2S in patients with multiple sclerosis
Authorea (Authorea)